Gossamer Bio (GOSS)
(Delayed Data from NSDQ)
$2.99 USD
-0.09 (-2.92%)
Updated Sep 24, 2025 04:00 PM ET
After-Market: $3.00 +0.01 (0.33%) 6:34 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Gossamer Bio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GOSS 2.99 -0.09(-2.92%)
Will GOSS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GOSS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GOSS
Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
GOSS: What are Zacks experts saying now?
Zacks Private Portfolio Services
GSK (GSK) Q2 Earnings and Revenues Beat Estimates
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates
Other News for GOSS
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names
Technical picture remains unchanged for GOSS after it falls 2.53% on September 23
GOSS rises 3.61% on September 23, leaving the technical picture intact
MACD Bearish Signal Line Cross appears for GOSS after 0.97% move